Deborah Birx - 21 Dec 2023 Form 4 Insider Report for Armata Pharmaceuticals, Inc. (ARMP)

Role
Chief Executive Officer, Director
Signature
/s/ Deborah Birx
Issuer symbol
ARMP
Transactions as of
21 Dec 2023
Net transactions value
$0
Form type
4
Filing time
26 Dec 2023, 21:53:29 UTC
Previous filing
19 Jul 2023
Next filing
18 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ARMP Common Stock Award $0 +200,000 $0.000000 200,000 21 Dec 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ARMP Stock Options (Right to Buy) Award $0 +200,000 $0.000000 200,000 21 Dec 2023 Common Stock 200,000 $2.39 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Twenty-five percent (25%) of the Stock Options shall vest on July 10th of each of 2024, 2025, 2026, and 2027.